Tonix Pharmaceuticals Holding (TNXP) Other Non Operating Income (2023 - 2025)
Historic Other Non Operating Income for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$1.2 million.
- Tonix Pharmaceuticals Holding's Other Non Operating Income fell 252727.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 44126.21%. This contributed to the annual value of -$2.1 million for FY2024, which is 22073.17% down from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Other Non Operating Income is -$1.2 million, which was down 252727.27% from -$2.0 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Other Non Operating Income high stood at $172000.0 for Q3 2023, and its period low was -$2.1 million during Q1 2025.
- Its 3-year average for Other Non Operating Income is -$861555.6, with a median of -$606000.0 in 2024.
- Over the last 5 years, Tonix Pharmaceuticals Holding's Other Non Operating Income had its largest YoY gain of 12558.14% in 2024, and its largest YoY loss of 2134285.71% in 2024.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Other Non Operating Income stood at $7000.0 in 2023, then plummeted by 21342.86% to -$1.5 million in 2024, then increased by 22.26% to -$1.2 million in 2025.
- Its Other Non Operating Income was -$1.2 million in Q3 2025, compared to -$2.0 million in Q2 2025 and -$2.1 million in Q1 2025.